Sermorelin With Coa

When procuring synthetic GHRH analogues for laboratory investigation, obtaining lot-specific batch documentation is essential for experimental validity. Sourcing Sermorelin with COA documentation ensures that researchers receive high-purity, structurally validated peptides suitable for in vitro assays and preclinical models.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

When procuring synthetic GHRH analogues for laboratory investigation, obtaining lot-specific batch documentation is essential for experimental validity. Sourcing Sermorelin with COA documentation ensures that researchers receive high-purity, structurally validated peptides suitable for in vitro assays and preclinical models.

Reviewed by PX1 Research scientific team

Key takeaways

  • [Sermorelin](/research-peptides/sermorelin) with a [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) refers to research-grade Sermorelin acetate supplied alongside lot-specific analytical documentation verifying chemical purity (typically ≥98% via RP-HPLC), molecular identity (via ESI-MS), net peptide content, and endotoxin limits (via LAL assay).
  • [Sermorelin](/research-peptides/sermorelin) acetate is a synthetic 29-amino acid peptide representing the active N-terminal sequence of endogenous Growth Hormone-Releasing Hormone (GHRH 1-29 amide).
  • A comprehensive [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) provides quantitative evidence of peptide identity and physical chemical properties.
  • Understanding the methodology behind standard quality control assays helps researchers critically interpret batch reports.

Direct Answer: What Is Sermorelin with COA?

Sermorelin with a Certificate of Analysis (COA) refers to research-grade Sermorelin acetate supplied alongside lot-specific analytical documentation verifying chemical purity (typically ≥98% via RP-HPLC), molecular identity (via ESI-MS), net peptide content, and endotoxin limits (via LAL assay). PX1 Research provides independently verified COAs from accredited testing laboratories with every lot.

A complete analytical dossier protects preclinical protocols from batch-to-batch variability, synthesis sequence truncation, residual solvent contamination, and bioburden interference. Investigators evaluating research peptides rely on these verified metrics to ensure baseline reproducibility across cell culture assays and animal tissue models.

Molecular Structure and Mechanism of Action in Preclinical Models

Sermorelin acetate is a synthetic 29-amino acid peptide representing the active N-terminal sequence of endogenous Growth Hormone-Releasing Hormone (GHRH 1-29 amide). Structurally, it contains the primary functional domain required to bind and activate the GHRH receptor (GHRHR), a G-protein-coupled receptor located on pituitary somatotrope cells. The full endogenous GHRH molecule consists of 44 amino acids, but preclinical literature confirms that the truncated 1-29 sequence retains full receptor binding affinity and intrinsic biological activity.

In vitro receptor binding assays indicate that upon ligand engagement, Sermorelin stimulates adenylate cyclase activity, triggering intracellular cyclic adenosine monophosphate (cAMP) accumulation and protein kinase A (PKA) pathway signal transduction. Preclinical studies suggest this signal cascade promotes transcription of the growth hormone (GH) gene and facilitates calcium-dependent exocytosis of GH storage vesicles.

Because of its physiological interaction with native receptor architecture, Sermorelin serves as a foundational tool in our preclinical research library for examining pulsatile neuroendocrine secretion, pituitary cell signaling dynamics, and downstream signaling pathways involving insulin-like growth factor 1 (IGF-1) expression in tissue culture models.

Key Parameters Detailed in a Sermorelin Certificate of Analysis

A comprehensive Certificate of Analysis provides quantitative evidence of peptide identity and physical chemical properties. When reviewing documentation for Sermorelin, researchers must inspect specific key analytical metrics to verify lot integrity prior to reconstitution.

First, Chemical Purity determined via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) measures the relative peak area of Sermorelin against secondary degradation products or synthetic side-products. Quality standards require a primary peak purity of ≥98.0%. Second, Identity Verification via Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular weight of the peptide. The theoretical monoisotopic mass of Sermorelin (C149H246N44O42S) is approximately 3357.9 Da; mass spectra must exhibit corresponding m/z ions matching this theoretical structure without unexpected adduct peaks.

Additional critical values include Net Peptide Content (distinguishing true peptide mass from residual counter-ions like acetate and bound moisture), Residual Solvent Analysis (verifying complete removal of synthesis solvents such as dimethylformamide and trifluoroacetic acid), and Appearance (confirming a uniform lyophilized white cake or powder free of particulate matter).

Analytical Verification: RP-HPLC and Mass Spectrometry

Understanding the methodology behind standard quality control assays helps researchers critically interpret batch reports. Learn more about these analytical methods in our overview of RP-HPLC and mass spectrometry testing. RP-HPLC separates chemical species based on hydrophobic interactions between the peptide analyte and a non-polar stationary phase (typically C18 silica columns). As an eluent gradient of acetonitrile and water containing 0.1% TFA flows through the column, components elute at specific retention times detected by UV absorbance at 214 nm and 280 nm.

Mass spectrometry acts as an orthogonal identity check. While HPLC demonstrates high resolution between closely related chemical species, it cannot definitively confirm chemical identity on its own. ESI-MS ionizes the purified sample, generating multi-charged protonated species ([M+H]+, [M+2H]2+, [M+3H]3+) that pass through a quadrupole or time-of-flight analyzer. Comparing observed mass-to-charge ratios to theoretical calculations confirms correct primary sequence assembly without sequence inversions or missing amino acid residues.

Endotoxin Testing and Bioburden Control for Cell Culture Safety

Endotoxic lipopolysaccharides (LPS)—outer membrane components of Gram-negative bacteria—are common contaminants in synthetic and recombinant laboratory reagents. In cell culture models, even trace quantities of endotoxin bind to Toll-like receptor 4 (TLR4), triggering inflammatory cytokine release, altering gene expression, and distorting metabolic research data.

For rigorous in vitro and preclinical applications, Sermorelin must undergo quantitative Limulus Amebocyte Lysate (LAL) testing or recombinant Factor C (rFC) assays. A robust COA lists measured endotoxin levels expressed in Endotoxin Units per milligram (EU/mg). Standard specifications for high-grade research peptides require endotoxin levels below 0.01 EU/mg, preventing background immunological noise during delicate cellular signaling experiments.

Comparative Analysis: Sermorelin vs. Related Secretagogues

When designing neuroendocrine or somatotrope secretion studies, investigators often compare GHRH fragments against modified analogues and ghrelin receptor agonists. For instance, Sermorelin represents the short-acting, native 1-29 sequence with a relatively rapid enzymatic degradation profile in plasma and buffer matrices. In contrast, modified peptide constructs such as CJC-1295 No DAC incorporate specific D-amino acid substitutions (e.g., D-Ala2) to confer enhanced resistance to dipeptidyl peptidase-IV (DPP-IV) cleavage, altering receptor activation kinetics in animal models.

Meanwhile, compounds acting through distinct receptor pathways, such as the selective growth hormone secretagogue receptor (GHS-R1a) agonists Ipamorelin and GHRP-2, stimulate somatotropes via the ghrelin pathway rather than the GHRH receptor. Comparing these classes allows researchers to investigate synergistic signaling mechanisms, receptor crosstalk, and differential receptor desensitization kinetics across diverse growth hormone secretagogues.

Preclinical Literature Overview: Focus Areas and Findings

Preclinical investigation into GHRH analogue mechanisms spans several decades of laboratory research. In vitro studies using cultured rat anterior pituitary cells demonstrate that acute exposure to Sermorelin induces rapid, concentration-dependent growth hormone release, accompanied by an elevation of intracellular cAMP.

In rodent models, research indicates that administration of GHRH 1-29 fragments supports normal somatotropinergic axis signaling without downregulating endogenous GHRH receptor expression when administered in a pulsatile manner. Furthermore, animal studies examining peripheral metabolic pathways suggest that GHRH receptor activation downstream influences hepatic IGF-1 transcription, nitrogen retention markers, and cellular protein synthesis pathways.

Recent preclinical literature has expanded into non-somatotropic tissue models. In vitro assays using cardiomyocyte cultures, neuronal lines, and microvascular endothelial cells indicate that GHRH receptors expressed outside the central nervous system may mediate cell survival, anti-apoptotic cascades, and tissue repair pathways independent of systemic growth hormone regulation.

Laboratory Storage, Reconstitution, and Stability Guidelines

Proper handling and storage protocols are vital to preserving the chemical stability of synthetic peptides upon delivery. Lyophilized Sermorelin acetate should be stored at -20°C or -80°C in a desiccated environment protected from direct light. Under these conditions, the dry peptide cake maintains structural integrity and resists hydrolysis or oxidative degradation for extended periods.

Reconstitution should be performed under aseptic laboratory conditions inside a laminar flow hood. For in vitro assay preparation, researchers typically reconstitute the lyophilized powder using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile physiological saline (0.9% NaCl). Gentle swirling or passive dissolution is recommended; vigorous vortexing or mechanical shaking can induce shear stress, leading to peptide aggregation or structural denaturation.

Once reconstituted in aqueous solution, Sermorelin should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles. Aliquots should be stored at 2°C to 8°C for short-term experimental protocols or frozen at -80°C for longer-term storage, keeping in mind that repeated thermal cycling accelerates amide bond hydrolysis.

PX1 Research Sourcing, Quality Control, and Traceability

PX1 Research is committed to supplying academic, biotechnology, and institutional laboratories with ultra-pure, rigorously characterized research peptides. All compounds are synthesized in state-of-the-art, GMP-compliant facilities within the United States, adherence to strict ISO 9001 and ISO 13485 manufacturing workflows.

Every batch of Sermorelin undergoes third-party verification performed by an independent ISO 17025 accredited testing laboratory. We utilize automated analytical systems to generate comprehensive COAs detailing HPLC purity profiles, ESI-MS spectra, Karl Fischer moisture content, and LAL endotoxin quantification. Every vial is labeled with a lot-specific barcode for complete batch traceability from raw material synthesis to final distribution.

Orders ship directly from our climate-controlled distribution centers located in California and Arizona. With same-day shipping on orders placed Monday through Friday, PX1 Research minimizes transit times and thermal exposure. Organizations seeking high-volume material for ongoing research programs can establish custom supply schedules via our wholesale research accounts.

Frequently Asked Questions

Where can I view or download the COA for PX1 Research Sermorelin?

Lot-specific Certificates of Analysis are available directly on the PX1 Research product page or by contacting technical support with your lot number. Every shipment includes batch tracking details corresponding to downloadable third-party testing documentation.

What third-party testing methods are used to verify Sermorelin purity?

Sermorelin is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chemical purity, Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight confirmation, Karl Fischer titration for moisture content, and Limulus Amebocyte Lysate (LAL) assays for endotoxin quantification.

What is the acceptable purity threshold for research-grade Sermorelin?

PX1 Research requires a minimum HPLC purity threshold of ≥98.0% for research-grade Sermorelin, ensuring negligible baseline interference from synthetic deletion sequences or chemical impurities during laboratory assays.

What endotoxin limit is acceptable for in vitro cellular research?

For sensitive cell culture and tissue assays, endotoxin levels should ideally remain below 0.01 EU/mg. Low endotoxin levels prevent non-specific immunological activation via TLR4 signaling pathways in cellular research.

How should lyophilized Sermorelin be stored upon arrival at the lab?

Lyophilized Sermorelin should be stored at -20°C or -80°C in a desiccated container away from light. Short-term storage of intact, sealed vials at 2°C to 8°C is acceptable during immediate experimental workflows.

How should Sermorelin be reconstituted for laboratory assays?

Reconstitute Sermorelin under a laminar flow hood using sterile bacteriostatic water or sterile 0.9% sodium chloride. Gently swirl the vial to facilitate dissolution without agitation or vortexing to prevent peptide aggregation.

How does Sermorelin differ structurally from CJC-1295?

Sermorelin consists of the native 29-amino acid N-terminal sequence of GHRH. CJC-1295 No DAC features four specific amino acid modifications (D-Ala2, Gln8, Ala15, Leu27) engineered to enhance resistance against enzymatic degradation by DPP-IV.

Are PX1 Research compounds intended for human clinical use or dosing?

No. All compounds supplied by PX1 Research are strictly intended for in vitro, cell culture, and preclinical laboratory research use only. They are not for human or animal consumption, medical treatment, or therapeutic application.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.